Reliance vs Ryerson
RS and RYZ side by side, both in wholesale trade-durable goods. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How RS and RYZ compare
Reliance is the larger company, worth 14 times as much as Ryerson ($22.3B against $1.6B).
Ryerson grew revenue faster over the last twelve months (31.5% versus 15.4% for Reliance).
Reliance keeps more of each dollar of sales as profit, with a net margin of 5.7% compared with −0.56% at Ryerson.
Both pay dividends: Reliance yields 1.1% and Ryerson 1.8%.
Reliance scores higher on the StockData Score (13 against 7 for Ryerson), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | RS | RYZ |
|---|---|---|
| Size and price | ||
| Market cap | $22.3B | $1.6B |
| Share price | $436.91 | $31.15 |
| Change, 1 year | 54.8% | 39.9% |
| Change, 5 years | 168% | 11.8% |
| Beta (5Y) | 0.80 | 1.36 |
| Employees | 16K | 850 |
| StockData Score | ||
| Total score | 13 (better) | 7 |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 3 (better) | 0 |
| Health score | 6 (better) | 3 |
| Dividend score | 2 | 2 |
| Valuation | ||
| P/E | 25.4× | – |
| P/S | 1.4× | 0.3× (better) |
| P/B | 3.0× | 1.3× (better) |
| EV/EBITDA | 15.7× | 13.8× (better) |
| P/FCF | 41.3× | – |
| FCF yield | 2.4% (better) | −8.1% |
| Fair value | $275.24 | $24.98 |
| Margin of safety | −58.7% | −24.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 15.4% | 31.5% (better) |
| Revenue growth, 5Y average | 10.2% (better) | 5.7% |
| Net income growth (TTM) | 21.1% | – |
| EPS growth (TTM) | 25.5% | – |
| EPS growth, 5Y average | 19.8% | – |
| Profitability | ||
| Gross margin | 28.2% (better) | 17.3% |
| Operating margin | 7.8% (better) | 0.32% |
| Net margin | 5.7% (better) | −0.56% |
| FCF margin | 3.4% (better) | −2.2% |
| Return on equity | 12.2% (better) | −3.1% |
| Return on invested capital | 10.9% (better) | 1.5% |
| Financial health | ||
| Debt / equity | 0.22 | 0.00 (better) |
| Net debt / EBITDA | 0.94 (better) | −0.34 |
| Interest coverage | 19.5× | – |
| Current ratio | 4.30 (better) | 2.21 |
| Altman Z-score | 6.69 (better) | 2.56 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.1% | 1.8% (better) |
| Years of dividend growth | 15 (better) | 0 |
| Dividend growth, 5Y average | 13.9% | – |
| Buyback yield | 2.2% | – |
| Shareholder yield | 3.4% (better) | 1.8% |
| Ownership | ||
| Held by institutions | 82.3% | 94.5% |
| Held by insiders | 0.43% | 6.4% |
| Insider net buying, 12 months | −$16.0M | −$2.5M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 2.5% | 2.6% |
Go deeper
- RS stock overview
- RS income statement
- RS valuation and score
- RYZ stock overview
- RYZ income statement
- RYZ valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.